TY - JOUR
T1 - Genome analysis of Pseudomonas aeruginosa bacteriophage KPP23, belonging to the family Siphoviridae
AU - Yamaguchi, Kotoe
AU - Miyata, Reina
AU - Shigehisa, Ryu
AU - Uchiyama, Jumpei
AU - Takemura-Uchiyama, Iyo
AU - Kato, Shin Ichiro
AU - Ujihara, Takako
AU - Sakaguchi, Yoshihiko
AU - Daibata, Masanori
AU - Matsuzaki, Shigenobu
N1 - Funding Information:
This study was supported by the Center for Innovative and Translational Medicine, Kochi System Glycobiology Center, and the Center of Biomembrane Functions Controlling Biological Systems, Kochi University, Kochi, Japan.
Publisher Copyright:
© 2014 Yamaguchi et al.
PY - 2014
Y1 - 2014
N2 - Bacteriophage (phage) therapy is expected to become an alternative therapy for Pseudomonas aeruginosa infections. P. aeruginosa phage KPP23 is a newly isolated phage belonging to the family Siphoviridae and may be a therapeutic phage candidate. We report its complete genome, which comprises 62,774 bp of double-stranded DNA containing 95 open reading frames.
AB - Bacteriophage (phage) therapy is expected to become an alternative therapy for Pseudomonas aeruginosa infections. P. aeruginosa phage KPP23 is a newly isolated phage belonging to the family Siphoviridae and may be a therapeutic phage candidate. We report its complete genome, which comprises 62,774 bp of double-stranded DNA containing 95 open reading frames.
UR - http://www.scopus.com/inward/record.url?scp=84999115087&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84999115087&partnerID=8YFLogxK
U2 - 10.1128/genomeA.00233-14
DO - 10.1128/genomeA.00233-14
M3 - Article
AN - SCOPUS:84999115087
SN - 2169-8287
VL - 2
JO - Microbiology Resource Announcements
JF - Microbiology Resource Announcements
IS - 3
M1 - e00233-14
ER -